You just read:

Merck Announces Positive Data Investigating the Use of Pembrolizumab in Patients with Advanced Triple-Negative Breast Cancer at 2014 San Antonio Breast Cancer Symposium

News provided by

Merck Canada Inc.

Dec 10, 2014, 08:30 ET